Ekso Bionics (EKSO) Tops Q1 EPS by 2c

Ekso Bionics (NASDAQ: EKSO) reported Q1 EPS of ($0.38), $0.02 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $2.38 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)